2. Academic Validation
  3. De novo design mini-binder proteins targeting the capsid-forming domain of type 2 PRRSV nucleocapsid protein to inhibit PRRSV replication in vitro

De novo design mini-binder proteins targeting the capsid-forming domain of type 2 PRRSV nucleocapsid protein to inhibit PRRSV replication in vitro

  • Int J Biol Macromol. 2025 Sep;323(Pt 2):147118. doi: 10.1016/j.ijbiomac.2025.147118.
Zhang Liu 1,  Ke Ming 2,  Banbin Xing 3,  Tongqi Gan 1,  Licheng Bai 1,  Junfei Zhu 2,  Lin Wei 2,  Zhizheng Wang 2,  Cheng Zhang 1,  Yibin Cheng 1,  Chao Zhai 1,  Wentao Cai 4,  Zigong Wei 5
Affiliations

Affiliations

  • 1 State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China.
  • 2 State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Animal Innovative Drug Research Center, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Hubei Jiangxia Laboratory, Wuhan, Hubei, PR China.
  • 3 State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Animal Innovative Drug Research Center, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China.
  • 4 State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China. Electronic address: wtcai@hubu.edu.cn.
  • 5 State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Animal Innovative Drug Research Center, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China; Hubei Jiangxia Laboratory, Wuhan, Hubei, PR China; National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China. Electronic address: weizigong@163.com.
PMID: 40865823 DOI: 10.1016/j.ijbiomac.2025.147118
Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) has caused huge economic losses to swine industry but there is no effective Antiviral drug. Nucleocapsid (N) protein is highly conserved in type 2 PRRSV and is considered as an important target for Antiviral development. Mini-binders are novel protein drugs de novo designed for a specific protein target using a computational approach, which has great application prospects. Here, we employed a Rosetta-based approach to design mini-binders targeting the capsid-forming domain of N protein of type 2 PRRSV. The hydrophobic surface of the target protein was selected as the binding site and the promising binding modes were extensively explored. Three highly thermostable mini-binders with molecular weight of approximately 6 kDa were identified. All Binders can penetrate the cell membrane and be distributed in the cytoplasm. Among them, binder 2 demonstrated robust anti-PRRSV efficacy in vitro, potently suppressing viral replication while exhibiting no interference with viral entry, internalization, or release. The binding between binder 2 and the capsid-forming domain of PRRSV N protein was confirmed by BLI assay and BiFC assay, indicating that the Antiviral mechanism matched the expectation. Our study provides new insights into developing novel anti-PRRSV agents.

Keywords

Mini-binder; PRRSV nucleocapsid protein; Protein de novo design.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z